David Monteith

Title: David Monteith: Innovator in Gamma-Hydroxybutyrate Formulations

Introduction

David Monteith is a notable inventor based in Lyons, France. He has made significant contributions to the field of pharmacology, particularly in the development of gamma-hydroxybutyrate formulations. With a total of 2 patents to his name, Monteith's work focuses on improving the pharmacokinetic properties of these formulations.

Latest Patents

Monteith's latest patents include innovative approaches to gamma-hydroxybutyrate. One patent details modified release gamma-hydroxybutyrate formulations that have improved pharmacokinetics. This patent emphasizes the therapeutic uses of these formulations. Another patent outlines methods of administering gamma-hydroxybutyrate formulations after a high-fat meal, providing a once-nightly dosage that enhances the effectiveness of the treatment.

Career Highlights

David Monteith is associated with Flamel Ireland Limited, where he applies his expertise in pharmaceutical innovations. His work has contributed to advancements in the therapeutic applications of gamma-hydroxybutyrate, showcasing his commitment to improving patient care through innovative solutions.

Collaborations

Monteith collaborates with talented professionals in his field, including Julien Grassot and Hervé Guillard. These partnerships enhance the research and development efforts at Flamel Ireland Limited, fostering a collaborative environment for innovation.

Conclusion

David Monteith stands out as an influential inventor in the realm of gamma-hydroxybutyrate formulations. His patents reflect a dedication to enhancing pharmacological treatments, ultimately benefiting patients in need.